Research view
Switch to patient viewMultiple sclerosis: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- CD20 17
- CD19 9
- PPAR 0
- NLRP3 0
- STAT3 0
- BCMA 13
- BTK 1
- IL-17 0
- NRF2 0
- TNF 0
- AQP4 0
- GLP-1 2
- AMPK 0
- BDNF 1
- AKT 0
- IL-6 0
- mTOR 0
- CD40 0
- JAK 0
- PI3K 0
- STING 0
- TREM2 0
- PD-1 0
- IL-1 0
- IL-4 0
- SIRT1 0
- TLR4 0
- AXL 0
- CGRP 0
- CSF1R 0
- HIF-1 0
- IL-23 0
- VEGF 1
- COX-2 0
- CTLA-4 0
- CXCR4 0
- ERK 0
- HMGB1 0
- HSP90 0
- PD-L1 0
- TYK2 1
- APOE 0
- CCR5 0
- CTNNB1 0
- EGFR 0
- FOXP3 0
- GPX4 0
- IDO1 0
- JNK 0
- PARP 0
- PTEN 0
- TP53 1
- ACE2 0
- APP 0
- BCL-2 0
- BRD4 0
- C9orf72 0
- CDK4/6 0
- G6PD 0
- HDAC 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF
European Commission (Horizon Europe) · HORIZON-ERC
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Molecular regulation of the axon–myelin interface in development and repair (MInDRe)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
Targeting myeloid cell states, actions and interactions in neuroinflammation (TACO)
European Commission (Horizon Europe) · HORIZON-ERC
Resolving CNS-to-Monocyte crosstalk In NeuroInflammatory Disease (REMIND)
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants (VaccinNate)
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
MANTIS - A unified framework for Multi-contrast ANalysis of TIssue microStructure
The disease is named only in the funder's project summary, not in the title.
10 of 46 running projects, newest first. Listed amounts together: €130.5m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 16
- Mendelian Randomization Analysis 66
- CRISPR-Cas Systems 3
- Gene Expression Profiling 39
- Sequence Analysis, RNA 6
- Whole Genome Sequencing 1
- Exome Sequencing 3
- Proteomics 34
- Metabolomics 21
- Mass Spectrometry 12
- Flow Cytometry 29
- Immunohistochemistry 10
- Xenograft Model Antitumor Assays 2
- Positron-Emission Tomography 29
- Magnetic Resonance Imaging 570
- Machine Learning 43
- Deep Learning 33
- Cohort Studies 183
- Genome-Wide Association Study 84
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.